Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma
- PMID: 22982885
- DOI: 10.1097/PAS.0b013e31825b37f0
Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma
Abstract
Multilocular cystic renal cell carcinoma (RCC) is an uncommon renal neoplasm composed of thin fibrous septa lining multiple cystic spaces and associated with an excellent prognosis. Clear cells with generally low-grade nuclear features line the cystic spaces and may be present within the fibrous septa, although solid mass-forming areas are by definition absent. Despite the excellent prognosis, molecular-genetic alterations are similar to those of clear cell RCC. Immunohistochemical staining characteristics, however, have not been well elucidated. We studied 24 cases of multilocular cystic RCC, classified according to the 2004 World Health Organization System. Immunohistochemical analysis was performed using an automated immunostainer for CD10, cytokeratin 7 (CK7), α-methylacyl-CoA-racemase, epithelial membrane antigen (EMA), cytokeratin CAM 5.2, carbonic anhydrase IX (CA-IX), estrogen/progesterone receptors, smooth muscle actin, PAX-2, and vimentin. Twenty-four cases of grade 1 to 2 clear cell RCC were stained for comparison. Multilocular cystic RCC and control cases of clear cell RCC showed the following results, respectively: CD10 (63%, 96%), CK7 (92%, 38%), α-methylacyl-CoA-racemase (21%, 67%), vimentin (58%, 33%), estrogen receptor (8%, 8%), CAM 5.2 (100%, 96%), EMA, CA-IX, PAX-2 (all 100%), and progesterone receptor (0%). Smooth muscle actin highlighted myofibroblastic cells within the septa of multilocular cystic RCC and the fine capillary vascular network of clear cell RCC. In summary, multilocular cystic RCC showed expression of common clear cell RCC markers CA-IX, EMA, and PAX-2, supporting the hypothesis that multilocular cystic RCC is a subtype of clear cell RCC. In contrast to clear cell RCC, tumors less frequently expressed CD10 (63% and often focal vs. 96% and diffuse) and more frequently expressed CK7 (92%), often diffusely (63%). Coexpression of CA-IX and CK7 represents a point of overlap with the recently described clear cell papillary RCC, which also may show a prominent cystic architecture. However, the latter lacks mutation of the VHL gene and deletion of chromosome 3p by molecular methodologies.
Similar articles
-
Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features.Pathol Oncol Res. 2015 Sep;21(4):893-9. doi: 10.1007/s12253-015-9898-7. Epub 2015 Feb 25. Pathol Oncol Res. 2015. PMID: 25712789
-
Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.Ann Diagn Pathol. 2013 Feb;17(1):58-62. doi: 10.1016/j.anndiagpath.2012.07.002. Epub 2012 Aug 14. Ann Diagn Pathol. 2013. PMID: 22898056
-
Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.Am J Surg Pathol. 2016 Feb;40(2):141-54. doi: 10.1097/PAS.0000000000000583. Am J Surg Pathol. 2016. PMID: 26752401
-
Recent advances of immunohistochemistry for diagnosis of renal tumors.Pathol Int. 2013 Aug;63(8):381-90. doi: 10.1111/pin.12080. Pathol Int. 2013. PMID: 23957913 Review.
-
Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.Eur Urol. 2010 Jul;58(1):75-83. doi: 10.1016/j.eururo.2010.03.015. Epub 2010 Mar 23. Eur Urol. 2010. PMID: 20359812 Review.
Cited by
-
Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas.Mol Cancer Res. 2016 Jul;14(7):589-98. doi: 10.1158/1541-7786.MCR-16-0115. Epub 2016 Jun 21. Mol Cancer Res. 2016. PMID: 27330105 Free PMC article. Review.
-
Recent publications by ochsner authors.Ochsner J. 2013 Summer;13(2):278-83. Ochsner J. 2013. PMID: 23789020 Free PMC article. No abstract available.
-
Clear cell renal cell carcinoma with cystic component similar to multilocular cystic renal neoplasm of low malignant potential: a rare pattern of cyst-dependent progression from multilocular cystic renal neoplasm of low malignant potential.Diagn Pathol. 2023 Feb 21;18(1):27. doi: 10.1186/s13000-023-01315-x. Diagn Pathol. 2023. PMID: 36810118 Free PMC article.
-
Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy.Mol Cancer. 2014 Feb 26;13:39. doi: 10.1186/1476-4598-13-39. Mol Cancer. 2014. PMID: 24568263 Free PMC article.
-
Renal cell carcinoma: Evolving and emerging subtypes.World J Clin Cases. 2013 Dec 16;1(9):262-75. doi: 10.12998/wjcc.v1.i9.262. World J Clin Cases. 2013. PMID: 24364021 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials